GAM
GSK icon

Garrison Asset Management’s GSK GSK Stock Holding History

Garrison Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,160
Closed -$209K – 104
2018
Q3 		$209K Sell
4,160
-1,360
-25% -$69.1K 0.1% 103
2018
Q2 		$278K Buy
5,520
+200
+4% +$10.1K 0.14% 96
2018
Q1 		$260K Hold
5,320
– – 0.15% 88
2017
Q4 		$236K Buy
5,320
+225
+4% +$10.4K 0.12% 96
2017
Q3 		$259K Buy
5,095
+276
+6% +$14K 0.15% 93
2017
Q2 		$260K Buy
4,819
+560
+13% +$29.9K 0.15% 89
2017
Q1 		$224K Sell
4,259
-446
-9% -$22.6K 0.13% 96
2016
Q4 		$226K Sell
4,705
-490
-9% -$24.2K 0.14% 94
2016
Q3 		$280K Hold
5,195
– – 0.18% 82
2016
Q2 		$281K Sell
5,195
-2,480
-32% -$131K 0.19% 81
2016
Q1 		$389K Sell
7,675
-44
-0.6% -$2.19K 0.27% 68
2015
Q4 		$389K Sell
7,719
-635
-8% -$32.4K 0.27% 65
2015
Q3 		$401K Sell
8,354
-64
-0.8% -$3.33K 0.29% 61
2015
Q2 		$438K Buy
8,418
+162
+2% +$9.12K 0.29% 62
2015
Q1 		$476K Sell
8,256
-906
-10% -$51.9K 0.32% 61
2014
Q4 		$526K Hold
9,162
– – 0.39% 52
2014
Q3 		$526K Sell
9,162
-400
-4% -$24.5K 0.39% 52
2014
Q2 		$639K Buy
9,562
+436
+5% +$29.5K 0.46% 51
2014
Q1 		$610K Sell
9,126
-452
-5% -$30.6K 0.48% 47
2013
Q4 		$639K Hold
9,578
– – 0.52% 48
2013
Q3 		$601K Sell
9,578
-301
-3% -$19.4K 0.53% 48
2013
Q2 		$617K Buy
+9,879
New +$627K 0.58% 47

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Garrison Asset Management's GSK Position: Q4 2018 in Review

Garrison Asset Management sold out of GSK (GSK) in Q4 2018, closing a stake of 4,160 shares — an estimated $209K sold.

Garrison Asset Management first reported a position in GSK in Q2 2013 and held it in 22 quarters. The position peaked at $639K in Q2 2014. 800 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

  • Garrison Asset Management reported no remaining GSK position as of Q4 2018 after selling out during the quarter.
  • Garrison Asset Management sold 4,160 GSK shares in Q4 2018, an estimated $209K.
  • Garrison Asset Management first reported a position in GSK in Q2 2013 and held it in 22 quarters.
  • Garrison Asset Management's GSK position peaked at $639K in Q2 2014.
  • 800 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on Garrison Asset Management's 13F filing for Q4 2018, filed 5 Feb 2019.